Status
Conditions
Treatments
About
This study is a single center, random participant selection, data analyst is blinded to patient identifiers, controlled clinical trial.
The proposed study is intended to establish safety and efficacy of quantifiable electrical biomarkers for migraine that can be used to confirm a diagnosis in people that have already been screened as positive for migraine using the gold standard participative criteria set out in the International Classification of Headache disorders-3 (ICHD-3) criteria.
It is hypothesized that specific brain signals can be used to distinguish between migraine patients with and without aura from normal control and tension- type headache control participants by EEG enhanced with machine learning software.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
● Age range: All participants and controls will be adults over 18, and no greater than 70
Exclusion criteria
● Under 18 years old
4.2.2 EXCLUSION CRITERIA FOR NORMAL CONTROLS
4.2.3 EXCLUSION CRITERIA FOR MIGRAINE WITHOUT AURA:
● Chronic migraine without aura
4.2.4 EXCLUSION CRITERIA FOR TENSION-TYPE HEADACHES:
20 participants in 2 patient groups
Loading...
Central trial contact
Gaurav Anand, MD, BSc; Mark S. Doidge, MD, BA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal